Terms: = Thyroid cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Prognosis
61 results:
1. thyroid dysfunction caused by exposure to environmental endocrine disruptors and the underlying mechanism: A review.
He J; Xu J; Zheng M; Pan K; Yang L; Ma L; Wang C; Yu J
Chem Biol Interact; 2024 Mar; 391():110909. PubMed ID: 38340975
[TBL] [Abstract] [Full Text] [Related]
2. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
3. HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer.
He Y; Ma Y; Zhu Y; Zhang J; Zhao S; Zhang D; Xu D; Li Y; Tong Z; Zhao W
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38214343
[TBL] [Abstract] [Full Text] [Related]
4. Brusatol attenuated proliferation and invasion induced by kras in differentiated thyroid cancer through inhibiting Nrf2.
Gong Z; Xue L; Vlantis AC; van Hasselt CA; Chan JYK; Fang J; Wang R; Yang Y; Li D; Zeng X; Tong MCF; Chen GG
J Endocrinol Invest; 2024 May; 47(5):1271-1280. PubMed ID: 38062319
[TBL] [Abstract] [Full Text] [Related]
5. Gene mutations as predictors of central lymph mode metastasis in cN0 PTC: A meta-analysis.
Ji J; Shi X
Clin Genet; 2024 Feb; 105(2):130-139. PubMed ID: 37985961
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours.
Yen CC; Yeh YM; Huang HY; Ting YL; Fu PA; Lin TC; Liu IT; Yen CJ
Target Oncol; 2023 Jul; 18(4):611-623. PubMed ID: 37347391
[TBL] [Abstract] [Full Text] [Related]
7. Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer.
Zeng Y; Ma W; Li L; Zhuang G; Luo G; Zhou H; Hao W; Liu Y; Guo F; Tian M; Ruan X; Gao M; Zheng X
Aging (Albany NY); 2023 Mar; 15(5):1668-1684. PubMed ID: 36917092
[TBL] [Abstract] [Full Text] [Related]
8. Medullary carcinoma of the colon: A comprehensive analysis of the National cancer Database.
Jabbal IS; Nagarajan A; Rivera C; Yaghi M; Liang H; Nahleh Z; Bejarano P; Berho M; Wexner S
Surg Oncol; 2022 Dec; 45():101856. PubMed ID: 36446307
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological and Molecular Features of Secondary cancer (Metastasis) to the thyroid and Advances in Management.
Nguyen M; He G; Lam AK
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328664
[TBL] [Abstract] [Full Text] [Related]
10. Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.
Semsar-Kazerooni K; Morand GB; Payne AE; da Silva SD; Forest VI; Hier MP; Pusztaszeri MP; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2022 Mar; 51(1):9. PubMed ID: 35246262
[TBL] [Abstract] [Full Text] [Related]
11. CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/kras and IGF2BP2/Myc axes.
Li J; Gao X; Zhang Z; Lai Y; Lin X; Lin B; Ma M; Liang X; Li X; Lv W; Lin Y; Zhang N
Mol Cancer; 2021 Oct; 20(1):138. PubMed ID: 34696797
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive analysis of aberrant alternative splicing related to carcinogenesis and prognosis of papillary thyroid cancer.
Zheng X; Feng L; Yin Y; Yu C; He X; Zhu J; Zhang M; Yu J; Xu M
Aging (Albany NY); 2021 Oct; 13(19):23149-23168. PubMed ID: 34628367
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1.
Galland L; Le Page AL; Lecuelle J; Bibeau F; Oulkhouir Y; Derangère V; Truntzer C; Ghiringhelli F
Oncoimmunology; 2021; 10(1):1957603. PubMed ID: 34377595
[TBL] [Abstract] [Full Text] [Related]
14. Whole-genome Sequencing of Follicular thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.
Paulsson JO; Rafati N; DiLorenzo S; Chen Y; Haglund F; Zedenius J; Juhlin CC
J Clin Endocrinol Metab; 2021 Oct; 106(11):3265-3282. PubMed ID: 34171097
[TBL] [Abstract] [Full Text] [Related]
15. Novel Histologic Classification of Small Tumor Cell Nests for Lung Adenocarcinoma With Prognostic and Etiological Significance: Small Solid Nests and Pure Micropapillary Nests.
Saito R; Ninomiya H; Okumura S; Mun M; Sasano H; Ishikawa Y
Am J Surg Pathol; 2021 May; 45(5):604-615. PubMed ID: 33835080
[TBL] [Abstract] [Full Text] [Related]
16. The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer.
Fujii A; Masuda T; Iwata M; Tobo T; Wakiyama H; Koike K; Kosai K; Nakano T; Kuramitsu S; Kitagawa A; Sato K; Kouyama Y; Shimizu D; Matsumoto Y; Utsunomiya T; Ohtsuka T; Yamanishi Y; Nakamura M; Mimori K
Cancer Sci; 2021 Apr; 112(4):1655-1668. PubMed ID: 33605496
[TBL] [Abstract] [Full Text] [Related]
17. Papillary thyroid carcinoma with hobnail features showing rapid progression and therapy resistance.
De Graef A; Van Den Heede K; Meert V; Van Slycke S
Acta Chir Belg; 2021 Apr; 121(2):77-85. PubMed ID: 33550925
[TBL] [Abstract] [Full Text] [Related]
18. [The possibility of using freely circulating DNA blood plasma in preoperative diagnosis of thyroid tumors].
Kachko VA; Vanushko VE; Platonova NM; Abrosimov AY; Tely Sheva EN; Snigireva GP
Probl Endokrinol (Mosk); 2020 Jun; 65(6):400-407. PubMed ID: 33351322
[TBL] [Abstract] [Full Text] [Related]
19. Histopathological subtyping is a prognostic factor in stage IV lung adenocarcinoma.
Da Cruz V; Yvorel V; Casteillo F; Tissot C; Luchez A; Bayle-Bleuez S; Fournel P; Tiffet O; Péoc'h M; Forest F
Lung Cancer; 2020 Sep; 147():77-82. PubMed ID: 32682188
[TBL] [Abstract] [Full Text] [Related]
20. Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas.
Matsubara D; Yoshimoto T; Soda M; Amano Y; Kihara A; Funaki T; Ito T; Sakuma Y; Shibano T; Endo S; Hagiwara K; Ishikawa S; Fukayama M; Murakami Y; Mano H; Niki T
Cancer Sci; 2020 Jun; 111(6):2183-2195. PubMed ID: 32237253
[TBL] [Abstract] [Full Text] [Related]
[Next]